文献速递泌尿生殖技术与安全PETCT

淋巴瘤患者FDG PET/CT检出肾脏肿块:影像特征鉴别原发性肾细胞癌与肾脏淋巴瘤累及

Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement.
PubMed 文献 · AJR Am J Roentgenol · 2017-01-17

回顾性分析36例淋巴瘤患者PET/CT检出的实性肾脏肿块,22例(61.1%)为肾细胞癌、14例(38.9%)为肾脏淋巴瘤。肾脏淋巴瘤的所有SUV指标均高于肾细胞癌(p<0.0001);所有肾脏淋巴瘤SUVmax高于5.98 g/mL(中位数10.99 g/mL),所有肾细胞癌SUVmax低于5.26 g/mL(中位数2.91 g/mL)。肿块大小和边缘在两者间无统计学显著差异。

要点

  • 淋巴瘤患者实性肾脏肿块中,肾脏淋巴瘤SUVmax均高于5.98 g/mL,肾细胞癌均低于5.26 g/mL。
  • 肾脏淋巴瘤的SUVmax、SUVmean及肿瘤/正常肾皮质、肿瘤/正常肝比值均高于肾细胞癌(p<0.0001)。
  • 肿块大小和边缘(边界清晰 vs 浸润性)在肾细胞癌与肾脏淋巴瘤间无统计学显著差异。

核心结论

  • PET/CT特征可能有助于鉴别淋巴瘤患者实性肾脏肿块中的肾细胞癌与肾脏淋巴瘤累及。

研究设计与样本

  • 回顾性研究,纳入36例因淋巴瘤分期或随访行PET/CT检出实性肾脏肿块的患者,以肾活检结果为参考标准,评估PET/CT的SUV指标及CT的大小、边缘和钙化。

关键影像表现/征象

  • CT上评估肾脏肿块大小、边缘(边界清晰 vs 浸润性)及钙化存在情况。
  • 肾细胞癌与肾脏淋巴瘤在肿块大小或边缘上无统计学显著差异。

诊断标准与关键数值

  • 所有肾脏淋巴瘤SUVmax高于5.98 g/mL(中位数10.99 g/mL)。
  • 所有肾细胞癌SUVmax低于5.26 g/mL(中位数2.91 g/mL)。
  • 肾脏淋巴瘤的所有SUV指标均高于肾细胞癌(p<0.0001)。
  • 记录的SUV指标包括SUVmax、SUVmean、肿瘤SUVmax/正常肾皮质SUVmax比值、肿瘤SUVmean/正常肾皮质SUVmean比值、肿瘤SUVmax/正常肝SUVmax比值、肿瘤SUVmean/正常肝SUVmean比值。

临床应用与阅片要点

  • 在淋巴瘤患者中评估实性肾脏肿块时,可结合SUVmax等PET/CT定量指标辅助鉴别肾细胞癌与肾脏淋巴瘤累及。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study is to analyze the 18F-FDG PET/CT features of solid renal masses detected in patients with lymphoma and to evaluate the ability of PET/CT to differentiate renal cell carcinoma (RCC) from renal lymphomatous involvement.

MATERIALS AND METHODS: Thirty-six patients with solid renal masses on PET/CT performed for staging or follow-up of lymphoma were evaluated retrospectively. The features recorded for each renal mass included the following standardized uptake values (SUVs) on PET/CT: the maximum SUV (SUVmax), the mean SUV (SUVmean), the ratio of the SUVmax of the tumor to that of the normal kidney cortex, the ratio of the SUVmean of the tumor to that of the normal kidney cortex, the ratio of the SUVmax of the tumor to that of the normal liver, and the ratio of the SUVmean of the tumor to that of the normal liver. Renal mass size and margins (well defined vs infiltrative) and the presence of calcifications were evaluated on CT. Renal biopsy results were used as the reference standard. Relationships between imaging parameters and histopathologic findings were assessed.

RESULTS: Of the 36 renal masses evaluated, 22 (61.1%) were RCCs and 14 (38.9%) were renal lymphomas. All SUV metrics were higher for renal lymphomas than for RCCs (p < 0.0001, for all). All renal lymphomas had an SUVmax higher than 5.98 g/mL (median, 10.99 g/mL), whereas all RCCs had an SUVmax lower than 5.26 g/mL (median, 2.91 g/mL). No statistically significant differences in mass size or margins were found between RCCs and renal lymphoma.

CONCLUSION: PET/CT features may be useful for differentiating RCCs from renal involvement in patients with lymphoma with solid renal masses.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Nicolau C, Sala E, Kumar A, et al. Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement. AJR Am J Roentgenol. 2017. PMID: 28095016. doi:10.2214/AJR.16.17133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。